Clinical Trials Logo

Hearing Loss, Sensorineural clinical trials

View clinical trials related to Hearing Loss, Sensorineural.

Filter by:

NCT ID: NCT04823494 Completed - Clinical trials for Hearing Loss, Sensorineural

Wear-Time Trial for Self-Fitting Hearing Aid

Start date: June 18, 2021
Phase: N/A
Study type: Interventional

This document describes a clinical validation study for a double-blind repeated-measures comparative study of the Great Nordic (GN) self-fitting method to a validated audiology-best-practices method when fitting the GN Self-fitting Hearing Aid, a device intended for persons aged 18-75 years old who have mild-to-moderate hearing loss. A crossover wear-time field trial will be conducted. The focus of the study is on the validity of the self-fitting process used to select appropriate frequency-gain characteristics for the GN Self-fitting Hearing Aid, and the safety and effectiveness of the device.

NCT ID: NCT04815343 Completed - Clinical trials for Cochlear Hearing Loss

Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios

Start date: November 20, 2020
Phase: N/A
Study type: Interventional

In this clinical trial, an un-controlled, repeated measures open design with within-subject comparison will be used to evaluate the effect of Naída Link M90 hearing aid and Naída CI M90 sound processor on sound perception. This design was shown to be successful in previous studies for the evaluation of sound coding strategies. Furthermore, a within-subject comparison decreases the variance in the results allowing for fewer subjects when the population that uses the investigational device is not large in general.

NCT ID: NCT04794842 Active, not recruiting - Meniere Disease Clinical Trials

Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection

Start date: August 1, 2021
Phase: Early Phase 1
Study type: Interventional

Intratympanic steroid injections are an accepted treatment for Meniere's disease and idiopathic sudden sensorineural hearing loss. This treatment is typically performed using local topical anesthesia. There is very limited research on the differences of medications and application procedures effect on patients' pain during the procedure.Topical Tetracaine solution and topical phenol have been shown to be effective as local anesthesia for the tympanic membrane when used for myringotomy. Currently there is no consensus on medication and technique however focally applied phenol is the more widely used technique. We believe this study can provide valuable information given the disadvantages of topical phenol including burning upon application as well as possible increase in persistent tympanic membrane perforation. The objectives are to determine the effectiveness of tetracaine drops for local anesthesia for intratympanic steroid injections compared to focal topical phenol application and to identify if tetracaine drops provides adequate anesthesia for intratympanic steroid injection with less pain on application than focal phenol.

NCT ID: NCT04777565 Completed - Clinical trials for Sensorineural Hearing Loss, Bilateral

Study of a Minimally Invasive Cochlear Access for Cochlear Implantation Via a Robotic Procedure

Start date: September 15, 2021
Phase: N/A
Study type: Interventional

The objectives of this study are to explore the efficacy and safety of a robotic procedure for a minimally invasive cochlear implantation.

NCT ID: NCT04750642 Active, not recruiting - Clinical trials for Sensorineural Hearing Loss

Cochlear Implant With Dexamethasone Eluting Electrode Array

Start date: October 4, 2021
Phase: N/A
Study type: Interventional

An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.

NCT ID: NCT04741048 Withdrawn - Clinical trials for Sensorineural Hearing Loss

Hearing Implant Performance in Adults With Low-Frequency Residual Hearing

Start date: March 8, 2021
Phase: N/A
Study type: Interventional

The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI624 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.

NCT ID: NCT04741009 Recruiting - Clinical trials for Sensorineural Hearing Loss

Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing

Start date: December 16, 2021
Phase: N/A
Study type: Interventional

The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.

NCT ID: NCT04733950 Recruiting - Clinical trials for Sensorineural Hearing Loss

Cochlear Implanted Listening Effort and Hearing Attention

EffICAtt
Start date: December 8, 2021
Phase: N/A
Study type: Interventional

Cochlear implant users perceive mainly sound amplitude modulation cues. Processing of these amplitude modulations can be subject to interferences, so that the perception of a modulation in a target sound can be impaired by a superimposed sound if this sound contains a similar modulation. Such phenomenon, which is observed both in subjects with normal-hearing and in cochlear-implant users, could be explained by difficulties to direct attention to relevant information in complex sound signals. Selective auditory attention also plays a crucial role in speech comprehension in cocktail-party situations where the speech of multiple talkers get mixed at the ear of a listener. Cochlear implant users typically struggle in these cocktail-party situations and report intense listening effort. The present clinical trial aims at evaluating the contribution of selective auditory attention for sound modulations to the listening effort of patients with cochlear implants and of healthy volunteers with normal-hearing during speech perception under cocktail-party-like conditions. Selective auditory attention abilities of patients and controls will be assessed using a psychoacoustical test whereby their ability to detect a target sound amplitude modulation will be measured both in the absence and in the presence of an interfering (i.e. distracting) amplitude modulation occurring in a distant spectral region from that of the target. The effect of this distractor's presence on modulation detection performance will serve as a behavioural index of the subject's auditory attention capacities. The attentional capacity index will then be tested as a predicting factor for the listening effort of the subject during a speech-in-noise consonant identification task. Listening effort will be measured from the pupil dilation response to the presented speech units (pseudowords). This study will enhance our understanding of cochlear implant user's perception and listening effort and will serve as a basis for prognostic tests of listening effort and of implantation success for cochlear implant candidates, based on a simple measurement of auditory attentional abilities.

NCT ID: NCT04724265 Recruiting - Clinical trials for Hearing Loss, Cochlear

Cytomegalovirus (CMV) Perilymphatic Fluid

CMVP
Start date: December 10, 2020
Phase: N/A
Study type: Interventional

In France, children cochlear implantation (CI) is performed 400 times per year. Causes of profound sensorineural hearing loss (SNHL) are represented by congenital malformation of the inner ear for 50 to 60%. Most of the remaining cases of CI in children are caused by congenital CMV infection. The proportion of CMV inducing SNHL with a CI in children is not clearly defined. During CI, we aim to collect a very small sample of perilymphatic fluid and to analyse it with a CMV polymerised-chain-reaction to evaluate the involvement of CMV in SNHL.

NCT ID: NCT04719728 Not yet recruiting - Clinical trials for Hearing Loss, Sensorineural, Bilateral

Evaluate Audiological Outcome of Cochlear Implant Program in Sohag University Hospital

Start date: March 1, 2021
Phase:
Study type: Observational

Evaluation of the outcome of cochlear implantation (CI) is very important issue since adequate hearing is linked to improved communication outcomes and school performance, development of speech and language, enhances speech perception in quiet and noise and even allows CI recipients to use the telephone. As well as there is a growing need for a widely used set of international quality standards on minimal outcome measurements to determine outcomes in CI recipients, monitor the auditory progress of CI recipients over time and to be able to relate on important issues as the most ideal age for implantation and the cut-off audiological thresholds for CI indication. This study will be conducted to evaluate outcome of cochlear implantation in sohag university hospital. Aim of work: To evaluate the outcome of cochlear implantation in Sohag university hospital.